Prolactin secreting pituitary carcinoma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1479402.
- Also identified by PMC identifier 1015342.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A man with a prolactin secreting pituitary carcinoma was treated by surgery and radiotherapy. Persistent hyperprolactinaemia partially responded to oral bromocriptine for four years. Serum prolactin then rose considerably with rapid, invasive tumour recurrence. Cytotoxic chemotherapy halted tumour progression for twelve months before fatal spread throughout the brain. Failure to normalise serum prolactin with bromocriptine may precede an aggressive course in patients with prolactinoma.
Medical subject headings
- Pituitary Neoplasms
- Prolactin
- Prolactinoma